Aimei Health Technology (NASDAQ:AFJK) Stock Price Down 0.3% – Time to Sell?

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) shares were down 0.3% during mid-day trading on Wednesday . The stock traded as low as $11.40 and last traded at $11.40. Approximately 25,114 shares were traded during trading, an increase of 837% from the average daily volume of 2,680 shares. The stock had previously closed at $11.43.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Aimei Health Technology in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

Aimei Health Technology Price Performance

The stock has a 50 day simple moving average of $11.31 and a two-hundred day simple moving average of $11.18. The company has a market cap of $69.77 million, a price-to-earnings ratio of 49.57 and a beta of -0.03.

Aimei Health Technology (NASDAQ:AFJK) last announced its quarterly earnings results on Wednesday, August 13th. The company reported $0.07 earnings per share for the quarter.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in AFJK. Crossingbridge Advisors LLC acquired a new position in Aimei Health Technology in the second quarter valued at approximately $2,147,000. Berkley W R Corp lifted its stake in shares of Aimei Health Technology by 23.6% in the 2nd quarter. Berkley W R Corp now owns 425,361 shares of the company’s stock valued at $4,704,000 after purchasing an additional 81,235 shares during the last quarter. Clear Street LLC lifted its stake in shares of Aimei Health Technology by 63.8% in the 2nd quarter. Clear Street LLC now owns 39,525 shares of the company’s stock valued at $441,000 after purchasing an additional 15,399 shares during the last quarter. Wellspring Financial Advisors LLC acquired a new position in shares of Aimei Health Technology in the 2nd quarter valued at $133,000. Finally, Polar Asset Management Partners Inc. acquired a new position in shares of Aimei Health Technology in the 1st quarter valued at $110,000. 45.58% of the stock is currently owned by institutional investors and hedge funds.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.